JP2006527252A5 - - Google Patents

Download PDF

Info

Publication number
JP2006527252A5
JP2006527252A5 JP2006516390A JP2006516390A JP2006527252A5 JP 2006527252 A5 JP2006527252 A5 JP 2006527252A5 JP 2006516390 A JP2006516390 A JP 2006516390A JP 2006516390 A JP2006516390 A JP 2006516390A JP 2006527252 A5 JP2006527252 A5 JP 2006527252A5
Authority
JP
Japan
Prior art keywords
compound
formula
nabh
methanol
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006516390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006527252A (ja
JP4780784B2 (ja
Filing date
Publication date
Priority claimed from GBGB0313677.7A external-priority patent/GB0313677D0/en
Application filed filed Critical
Publication of JP2006527252A publication Critical patent/JP2006527252A/ja
Publication of JP2006527252A5 publication Critical patent/JP2006527252A5/ja
Application granted granted Critical
Publication of JP4780784B2 publication Critical patent/JP4780784B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006516390A 2003-06-13 2004-06-09 Gcs阻害性ピペリジン誘導体 Expired - Fee Related JP4780784B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0313677.7 2003-06-13
GBGB0313677.7A GB0313677D0 (en) 2003-06-13 2003-06-13 Novel compound
PCT/GB2004/002450 WO2004111001A1 (en) 2003-06-13 2004-06-09 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl) piperidine as glucosylceramide synthase (gcs)

Publications (3)

Publication Number Publication Date
JP2006527252A JP2006527252A (ja) 2006-11-30
JP2006527252A5 true JP2006527252A5 (cg-RX-API-DMAC7.html) 2011-07-28
JP4780784B2 JP4780784B2 (ja) 2011-09-28

Family

ID=27590018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006516390A Expired - Fee Related JP4780784B2 (ja) 2003-06-13 2004-06-09 Gcs阻害性ピペリジン誘導体

Country Status (11)

Country Link
US (1) US8022219B2 (cg-RX-API-DMAC7.html)
EP (1) EP1641755B1 (cg-RX-API-DMAC7.html)
JP (1) JP4780784B2 (cg-RX-API-DMAC7.html)
CN (1) CN100422150C (cg-RX-API-DMAC7.html)
AU (1) AU2004247468B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0411293A8 (cg-RX-API-DMAC7.html)
CA (1) CA2528322C (cg-RX-API-DMAC7.html)
ES (1) ES2391634T3 (cg-RX-API-DMAC7.html)
GB (1) GB0313677D0 (cg-RX-API-DMAC7.html)
IL (1) IL172541A (cg-RX-API-DMAC7.html)
WO (1) WO2004111001A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0100889D0 (en) 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
ES2393331T3 (es) 2002-07-17 2012-12-20 Actelion Pharmaceuticals Ltd. Derivados de piperidintriol como inhibidores de la glucosiliceramida sintasa
AU2003248960B2 (en) 2002-07-17 2009-06-25 Idorsia Pharmaceuticals Ltd Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
GB0313677D0 (en) 2003-06-13 2003-07-16 Oxford Glycosciences Uk Ltd Novel compound
GB0313678D0 (en) * 2003-06-13 2003-07-16 Oxford Glycosciences Uk Ltd Novel compounds
JP5047941B2 (ja) 2005-03-23 2012-10-10 アクテリオン ファーマシューティカルズ リミテッド 免疫調節物質としての水素付加されたベンゾ(c)チオフェン誘導体
US20140350049A1 (en) 2011-11-29 2014-11-27 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of darier disease
CN108700594B (zh) 2015-11-18 2021-06-29 建新公司 多囊性肾病的生物标志物及其用途
WO2020193746A1 (en) 2019-03-28 2020-10-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival of patients suffering from melanoma
US12612380B2 (en) 2019-05-10 2026-04-28 Alectos Therapeutics 1Nc Non-lysosomal glucosylceramidase inhibitors and uses thereof
PE20231423A1 (es) 2020-05-07 2023-09-13 Alectos Therapeutics Inc Inhibidores de glucosilceramidasa no lisosomal y los usos de los mismos

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE3007078A1 (de) 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
DE3024901A1 (de) 1980-07-01 1982-01-28 Bayer Ag, 5090 Leverkusen Herbizide mittel auf basis von piperidin-derivaten
DE3247615A1 (de) 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3737523A1 (de) 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel
US5003072A (en) 1988-11-03 1991-03-26 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
JPH02306962A (ja) 1989-05-19 1990-12-20 Meiji Seika Kaisha Ltd 新規n―置換―1―デオキシノジリマイシン誘導体及びそれを含有する癌細胞転移抑制剤
JPH0324057A (ja) 1989-06-22 1991-02-01 Tosoh Corp ポリヒドロキシピペリジン類及びその製造法
WO1991003242A1 (en) 1989-09-07 1991-03-21 Nippon Shinyaku Co., Ltd. Antiviral drug
EP0536402A4 (en) 1990-06-29 1993-05-12 Nippon Shinyaku Company, Limited Piperidine derivative
US5276120A (en) 1991-05-30 1994-01-04 The Scripps Research Institute Process for forming omega-deuxy-azasugars
JP3506434B2 (ja) 1993-05-05 2004-03-15 ロシュ ダイアグノスティックス ゲーエムベーハー ブレビバクテリウム・ステロリカム由来のコレステロールオキシダーゼ
US5798366A (en) 1993-05-13 1998-08-25 Monsanto Company Method for treatment of CNS-involved lysosomal storage diseases
US6291657B1 (en) 1993-05-13 2001-09-18 Monsanto Company Deoxygalactonojirimycin derivatives
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
US6177447B1 (en) 1996-07-15 2001-01-23 Universiteit Van Amsterdam Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors
IL132170A0 (en) 1997-05-06 2001-03-19 Novo Nordisk As Novel heterocyclic compounds
WO1999001555A1 (en) 1997-07-03 1999-01-14 The United States Of America Represented By The Secretary, Department Of Health And Human Services Genes for niemann-pick type c disease
JP2001522833A (ja) 1997-11-10 2001-11-20 ジー・ディー・サール・アンド・カンパニー 多剤耐性を治療するためのアルキル化イミノ糖類の使用
US6610703B1 (en) 1998-12-10 2003-08-26 G.D. Searle & Co. Method for treatment of glycolipid storage diseases
WO2000056334A1 (en) 1999-03-19 2000-09-28 The Trustees Of Boston College Use of imino sugars for anti-tumor therapy
GB9909064D0 (en) 1999-04-20 1999-06-16 Oxford Glycosciences Uk Ltd Therapies
GB0100889D0 (en) 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
JP2003505430A (ja) 1999-07-26 2003-02-12 ジー・ディー・サール・アンド・カンパニー デオキシノジリマイシンの長鎖n−アルキル誘導体およびグルコセレブロシダーゼ酵素の糖脂質異常蓄積疾患の治療用の薬剤の製造のための使用
DE60037664T2 (de) 1999-08-10 2008-12-24 The Chancellor, Masters And Scholars Of The University Of Oxford Langkettige n-alkyl verbindungen und deren oxa-derivate zur verwendung als anitvirale mittel
US7256005B2 (en) 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
WO2002055489A2 (en) 2000-12-27 2002-07-18 Univ Columbia Pim kinase-related methods
DE60308378T2 (de) 2002-03-13 2007-09-20 Unither Pharmaceuticals, Inc. Nicht-Hormonal Verfahren zur männlichen Verhütung
AU2003248960B2 (en) * 2002-07-17 2009-06-25 Idorsia Pharmaceuticals Ltd Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
ES2393331T3 (es) 2002-07-17 2012-12-20 Actelion Pharmaceuticals Ltd. Derivados de piperidintriol como inhibidores de la glucosiliceramida sintasa
GB0313678D0 (en) * 2003-06-13 2003-07-16 Oxford Glycosciences Uk Ltd Novel compounds
GB0313677D0 (en) 2003-06-13 2003-07-16 Oxford Glycosciences Uk Ltd Novel compound
GB0400812D0 (en) 2004-01-14 2004-02-18 Celltech R&D Ltd Novel compounds

Similar Documents

Publication Publication Date Title
JP2006527253A5 (cg-RX-API-DMAC7.html)
US8227609B2 (en) Process for purifying noroxymorphone compounds
JP6383403B2 (ja) β−3作動薬および中間体の製造方法
Malkov et al. Organocatalysis with a fluorous tag: asymmetric reduction of imines with trichlorosilane catalyzed by amino acid-derived formamides
US20070281958A1 (en) Preparation of oxycodone
JP2009541429A5 (cg-RX-API-DMAC7.html)
CN101801977B (zh) 吗啡生物碱和托烷生物碱的n-脱甲基化的方法
Kuninobu et al. Reactions and Mechanistic Studies of Rhenium-Catalyzed Insertion of α, β-Unsaturated Carbonyl Compounds into a C–H Bond
CN113457736A (zh) 壳聚糖/纤维素复合微球固载铜在催化α,β-不饱和羰基化合物的硅加成反应中的应用
CN101585798A (zh) 光学活性化合物1-(3-苯甲酰氧基丙基)-5-(2-(1-苯基乙基胺)丙基)-7-氰基吲哚啉及其制备方法和用途
JP4959327B2 (ja) ロタキサン化合物、ロタキサン化合物が結合した固体基板及びこれを利用したバイオチップ
Dai et al. Palladium (II)‐Catalyzed One‐Pot Enantioselective Synthesis of Arylglycine Derivatives from Ethyl Glyoxylate, p‐Toluenesulfonyl Isocyanate and Arylboronic Acids
US20100168414A1 (en) Processes for preparing ezetimibe and intermediate compounds useful for the preparation thereof
EP3045459A1 (en) Method for preparing intermediate compound of sitagliptin
ATE557029T1 (de) Feste, mit phosphordendrimeren funktionalisierte träger, verfahren zu deren herstellung und deren verwendungen
JP4239972B2 (ja) 不活性メチレンの重水素化方法
CN1267282A (zh) 制备氨基芳基炔的方法
JP2004527509A5 (cg-RX-API-DMAC7.html)
JP2010517998A5 (cg-RX-API-DMAC7.html)
Bouamaied et al. Synthesis and spectroscopic properties of porphyrin-substituted uridine and deoxyuridine
JP2001316397A5 (cg-RX-API-DMAC7.html)
Park et al. Cp* Co (III)‐catalyzed C–H functionalization of bioactive heterocyclic motifs
CN115819258A (zh) 一种利用含膦氧双键催化剂的西格列汀中间体的制备方法
CN110372519B (zh) 一种3-氨基茚类化合物的合成方法
Moura et al. Asymmetric aza-Michael addition under ultra-high pressure: short bias to polyhydroxylated piperidines